Investegate announcements from Dante Genomics, Longenesis Partners with Dante Genomics to Offer Whole Genome Sequencing Solutions for Women’s Health in Europe
Dante Genomics, a global leader in genomics and precision medicine, today announced the creation of Genomic Biopharma Inc., a separate drug discovery and development company to distinguish the separate business streams of each entity. Genomic Biopharma Inc. will present two abstracts on two drug programs at the .
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company’s.
Investegate announcements from Dante Genomics, Dante Genomics Unveils Digital Health Population Genomic Programs at the United Nations General Assembly Science Summit